+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Injectable Ketamine Market - Global Forecast 2026-2032- Product Image
Injectable Ketamine Market - Global Forecast 2026-2032- Product Image
Sale

Injectable Ketamine Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134484
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Injectable Ketamine Market is projected to reach USD 860.56 Million in 2026. It is expected to continue growing at a CAGR of 5.21%, reaching USD 1.16 Billion by 2032.

Injectable Ketamine: Executive Summary and Market Context

Injectable ketamine is used in clinical settings for anesthesia, procedural sedation, acute pain management, and selected psychiatric applications. Its value proposition is linked to rapid onset, dissociative anesthesia, analgesic properties, and utility when conventional approaches are unsuitable. Use remains dependent on indication, patient selection, clinical supervision, product quality, and applicable regulation.

Clinical Practice Is Shifting Toward Protocolized, Safety-Centered Use

The landscape is being reshaped by broader interest in ketamine-assisted care, increasing emphasis on standardized dosing and monitoring, and greater scrutiny of off-label psychiatric use. Healthcare organizations are strengthening consent procedures, screening for contraindications, recovery protocols, documentation, and follow-up. The direction of practice is toward multidisciplinary governance rather than unsupervised or loosely defined treatment models.

Artificial Intelligence Supports Triage, Monitoring, and Evidence Development

Artificial intelligence can contribute to patient screening, clinical decision support, adverse-event detection, documentation, and analysis of treatment-response data. Its responsible use requires validated datasets, explainable outputs, clinician oversight, privacy safeguards, and clear accountability. AI does not replace trained personnel, physiologic monitoring, or emergency-readiness requirements during injectable ketamine administration.

Regional Differences Reflect Regulation, Infrastructure, and Clinical Capacity

North America has substantial clinical infrastructure and active discussion of psychiatric and pain applications, alongside strong attention to controlled-substance governance. Europe emphasizes harmonized quality standards while retaining country-level differences in prescribing and reimbursement. Asia-Pacific combines advanced hospital systems with varied access and regulatory frameworks. Latin America faces uneven specialist capacity and monitoring access. The Middle East is developing specialized services within diverse regulatory environments, while Africa’s adoption is shaped by medicine availability, workforce constraints, and hospital capacity.

Cross-Group Patterns: Alignment on Safety, Variation in Access

ASEAN countries show differing levels of regulatory maturity, specialist availability, and hospital capability. BRICS members reflect wide variation in public-sector access, domestic pharmaceutical capacity, and clinical protocols. European Union systems operate within shared medicines principles but retain national implementation differences. G7 countries generally have advanced monitoring and research infrastructure, while NATO members span highly diverse healthcare systems. GCC countries are investing in specialized healthcare capacity, although rules governing controlled medicines and psychiatric services differ across members.

Country Insights Reveal Distinct Regulatory and Care Pathways

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally have established anesthesia services and formal medicine controls, but differ in accepted indications, reimbursement, and oversight of off-label care. Brazil, Mexico, India, China, and Russia combine significant clinical need with varied access, regulatory processes, and regional disparities in specialist services. Across these countries, implementation depends on licensed supply, trained clinicians, monitoring equipment, emergency protocols, and locally compliant documentation.

Leaders Should Build Governance Before Expanding Injectable Ketamine Services

Industry leaders should define indication-specific protocols, credential administering clinicians, and establish independent clinical governance. Programs should use structured screening, informed consent, medication reconciliation, continuous physiologic monitoring, recovery observation, adverse-event reporting, and longitudinal follow-up. Leaders should also assess supply-chain integrity, staff training, data protection, referral pathways, and local controlled-substance requirements. Evidence generation should prioritize clinically meaningful outcomes, transparent reporting, and responsible evaluation of AI-enabled tools.

Methodology: Evidence-Led Assessment of Clinical and Operating Conditions

This executive summary uses a structured qualitative assessment of injectable ketamine across clinical indications, regulation, care delivery, technology, infrastructure, and geographic conditions. The analysis compares the required regions, country groupings, and countries using publicly established principles of anesthesia safety, controlled-medicine governance, healthcare capacity, and responsible AI adoption. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis.

Conclusion: Responsible Integration Is the Central Strategic Priority

Injectable ketamine’s role is shaped less by pharmacology alone than by the quality of clinical governance surrounding its use. Durable progress depends on appropriate patient selection, trained teams, reliable medicines, standardized monitoring, ethical evidence generation, and regulatory alignment. Organizations that treat safety, accountability, and equitable access as foundational will be better positioned to integrate injectable ketamine into appropriate care pathways.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Injectable Ketamine Market, by Indication
7.1. Introduction
7.2. Anesthesia
7.3. Pain Management
7.4. Post-Traumatic Stress Disorder
7.5. Treatment-Resistant Depression
8. Injectable Ketamine Market, by Product Type
8.1. Introduction
8.2. Esketamine
8.2.1. Brand
8.2.2. Generic
8.3. Racemic Ketamine
9. Injectable Ketamine Market, by Route
9.1. Introduction
9.2. Intramuscular Injection
9.3. Intravenous Infusion
10. Injectable Ketamine Market, by Formulation
10.1. Introduction
10.2. Prefilled Syringe
10.3. Vial
11. Injectable Ketamine Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Center
11.3. Hospital
11.4. Outpatient Clinic
12. Injectable Ketamine Market, by Distribution Channel
12.1. Introduction
12.2. Online
12.3. Offline
13. Injectable Ketamine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Injectable Ketamine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Injectable Ketamine Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Anhui Wanhe Pharmaceutical Co., Ltd.
17.2. Aspen Pharmacare Holdings Limited
17.3. B. Braun Melsungen AG
17.4. Baxter International Inc.
17.5. Ciron Drugs & Pharmaceuticals Pvt. Ltd.
17.6. Dr. Reddy's Laboratories Ltd.
17.7. Farbe Firma Pvt. Ltd.
17.8. Fresenius Kabi AG
17.9. Gland Pharma Ltd.
17.10. Global Calcium Pvt. Ltd.
17.11. Hikma Pharmaceuticals PLC
17.12. Ipca Laboratories Ltd.
17.13. Jiangsu Hengrui Medicine Co., Ltd.
17.14. Johnson Matthey PLC
17.15. Mallinckrodt Pharmaceuticals Holdings, Inc.
17.16. Neon Laboratories Ltd.
17.17. Pfizer Inc.
17.18. Samarth Pharma Pvt. Ltd.
17.19. Sandoz International GmbH
17.20. Seqens SAS
17.21. Sun Pharmaceutical Industries Ltd.
17.22. Supriya Lifescience Ltd.
17.23. Swiss Parenterals Pvt. Ltd.
17.24. Taj Pharmaceuticals Ltd.
17.25. Teva Pharmaceutical Industries Ltd.
17.26. Troikaa Parenterals Pvt. Ltd.
17.27. Umedica Laboratories Pvt. Ltd.
17.28. Verve Human Care Laboratories
17.29. Viatris Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Injectable Ketamine Market, Years Considered for the Study
FIGURE 2. Global Injectable Ketamine Market, Research Design
FIGURE 3. Global Injectable Ketamine Market, Research Framework
FIGURE 4. Global Injectable Ketamine Market, Data Triangulation
FIGURE 5. Global Injectable Ketamine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Injectable Ketamine Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Injectable Ketamine Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Injectable Ketamine Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Injectable Ketamine Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Injectable Ketamine Market Size, by Route, 2025 vs 2032 (%)
FIGURE 11. Global Injectable Ketamine Market Size, by Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Injectable Ketamine Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 13. Global Injectable Ketamine Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Injectable Ketamine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Injectable Ketamine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Injectable Ketamine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Injectable Ketamine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Injectable Ketamine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Injectable Ketamine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Injectable Ketamine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Injectable Ketamine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Injectable Ketamine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Injectable Ketamine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Injectable Ketamine Market Segmentation & Coverage
TABLE 2. Global Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Anesthesia Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Anesthesia Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Anesthesia Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Pain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Pain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Pain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Post-Traumatic Stress Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Post-Traumatic Stress Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Post-Traumatic Stress Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Treatment-Resistant Depression Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Treatment-Resistant Depression Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Treatment-Resistant Depression Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 17. Global Esketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Esketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Esketamine Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Brand Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Brand Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Brand Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Racemic Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Racemic Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Racemic Ketamine Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 30. Global Intramuscular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Intramuscular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Intramuscular Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Intravenous Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Intravenous Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Intravenous Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 37. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 44. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Outpatient Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Outpatient Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Outpatient Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 54. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 69. North America Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 71. North America Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. North America Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 73. North America Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 74. North America Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 75. North America Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Latin America Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Latin America Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 79. Latin America Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 80. Latin America Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 81. Latin America Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 82. Latin America Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 83. Latin America Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Latin America Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Europe Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Europe Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 87. Europe Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 88. Europe Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 89. Europe Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 90. Europe Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 91. Europe Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Europe Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Middle East Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Middle East Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 95. Middle East Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. Middle East Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 97. Middle East Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 98. Middle East Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 99. Middle East Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Middle East Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Africa Injectable Ketamine Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Africa Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 103. Africa Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Africa Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 105. Africa Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 106. Africa Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 107. Africa Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Africa Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. Global Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 112. ASEAN Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. ASEAN Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 114. ASEAN Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 115. ASEAN Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 116. ASEAN Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. ASEAN Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. GCC Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. GCC Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 120. GCC Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. GCC Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 122. GCC Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 123. GCC Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 124. GCC Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. GCC Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. European Union Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 128. European Union Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. European Union Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 130. European Union Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 131. European Union Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 132. European Union Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. European Union Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. BRICS Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. BRICS Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 136. BRICS Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. BRICS Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 138. BRICS Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 139. BRICS Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 140. BRICS Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. BRICS Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. G7 Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. G7 Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 144. G7 Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. G7 Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 146. G7 Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 147. G7 Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 148. G7 Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. G7 Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. NATO Injectable Ketamine Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. NATO Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. NATO Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 154. NATO Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 155. NATO Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 156. NATO Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. NATO Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. Global Injectable Ketamine Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. United States Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 160. United States Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 161. United States Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. United States Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 163. United States Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 164. United States Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 165. United States Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. United States Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Canada Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 168. Canada Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 169. Canada Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. Canada Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 171. Canada Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 172. Canada Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 173. Canada Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Canada Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Mexico Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 176. Mexico Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 177. Mexico Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. Mexico Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 179. Mexico Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 180. Mexico Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 181. Mexico Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Mexico Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. Brazil Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 184. Brazil Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 185. Brazil Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. Brazil Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 187. Brazil Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 188. Brazil Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 189. Brazil Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Brazil Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. United Kingdom Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 192. United Kingdom Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 193. United Kingdom Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 194. United Kingdom Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 195. United Kingdom Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 196. United Kingdom Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 197. United Kingdom Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. United Kingdom Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Germany Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 200. Germany Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 201. Germany Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Germany Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 203. Germany Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 204. Germany Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 205. Germany Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Germany Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. France Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 208. France Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 209. France Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. France Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 211. France Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 212. France Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 213. France Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. France Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. Russia Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 216. Russia Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 217. Russia Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Russia Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 219. Russia Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 220. Russia Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 221. Russia Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Russia Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Italy Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 224. Italy Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 225. Italy Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Italy Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 227. Italy Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 228. Italy Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 229. Italy Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Italy Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. Spain Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 232. Spain Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 233. Spain Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. Spain Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 235. Spain Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 236. Spain Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 237. Spain Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Spain Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. China Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 240. China Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 241. China Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. China Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 243. China Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 244. China Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 245. China Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. China Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. India Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 248. India Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 249. India Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. India Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 251. India Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 252. India Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 253. India Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. India Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. Japan Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 256. Japan Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 257. Japan Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. Japan Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 259. Japan Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 260. Japan Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 261. Japan Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Japan Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. Australia Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 264. Australia Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 265. Australia Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. Australia Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 267. Australia Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 268. Australia Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 269. Australia Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Australia Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. South Korea Injectable Ketamine Market Size, 2017-2032 (USD Million)
TABLE 272. South Korea Injectable Ketamine Market Size, by Indication, 2017-2032 (USD Million)
TABLE 273. South Korea Injectable Ketamine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. South Korea Injectable Ketamine Market Size, by Esketamine, 2017-2032 (USD Million)
TABLE 275. South Korea Injectable Ketamine Market Size, by Route, 2017-2032 (USD Million)
TABLE 276. South Korea Injectable Ketamine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 277. South Korea Injectable Ketamine Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. South Korea Injectable Ketamine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. Global Injectable Ketamine Market Share, by Key Player, 2025
TABLE 280. Global Injectable Ketamine Market, Key Experts

Companies Mentioned

  • Anhui Wanhe Pharmaceutical Co., Ltd.
  • Aspen Pharmacare Holdings Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Farbe Firma Pvt. Ltd.
  • Fresenius Kabi AG
  • Gland Pharma Ltd.
  • Global Calcium Pvt. Ltd.
  • Hikma Pharmaceuticals PLC
  • Ipca Laboratories Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Johnson Matthey PLC
  • Mallinckrodt Pharmaceuticals Holdings, Inc.
  • Neon Laboratories Ltd.
  • Pfizer Inc.
  • Samarth Pharma Pvt. Ltd.
  • Sandoz International GmbH
  • Seqens SAS
  • Sun Pharmaceutical Industries Ltd.
  • Supriya Lifescience Ltd.
  • Swiss Parenterals Pvt. Ltd.
  • Taj Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Troikaa Parenterals Pvt. Ltd.
  • Umedica Laboratories Pvt. Ltd.
  • Verve Human Care Laboratories
  • Viatris Inc.

Related Topics

Related Reports

Ketamine Clinic Market Report 2026 - Product Image

Ketamine Clinic Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Ketamine Clinic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Ketamine Clinic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Ketamine Clinic Market Outlook 2026-2034: Market Share and Growth Analysis - Product Image

Ketamine Clinic Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Ketamine (CAS 6740-88-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Ketamine (CAS 6740-88-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 51 Pages
  • Global
From
Ketamine Hydrochloride (CAS 1867-66-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Ketamine Hydrochloride (CAS 1867-66-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.